Where is the semantic system? A critical review and meta-analysis of 120 functional neuroimaging studies
Semantic memory refers to knowledge about people, objects, actions, relations, self, and
culture acquired through experience. The neural systems that store and retrieve this information …
culture acquired through experience. The neural systems that store and retrieve this information …
The neurobiology of semantic memory
Semantic memory includes all acquired knowledge about the world and is the basis for nearly
all human activity, yet its neurobiological foundation is only now becoming clear. Recent …
all human activity, yet its neurobiological foundation is only now becoming clear. Recent …
Phase transitions in monolayers
CM Knobler, RC Desai - Annual Review of Physical Chemistry, 1992 - annualreviews.org
When we began this review, we intended to write a chapter entitled," Phase transitions in
two-dimensional systems." It soon became evident, however, that it was impossible to cover so …
two-dimensional systems." It soon became evident, however, that it was impossible to cover so …
[HTML][HTML] Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
…, K Davletov, V De la Cruz-Góngora, R Desai… - The Lancet …, 2021 - thelancet.com
Background Regularly updated data on stroke and its pathological types, including data on
their incidence, prevalence, mortality, disability, risk factors, and epidemiological trends, are …
their incidence, prevalence, mortality, disability, risk factors, and epidemiological trends, are …
piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells
…, R Desai, M Mileikovsky, R Hämäläinen, R Cowling… - nature, 2009 - nature.com
Transgenic expression of just four defined transcription factors (c-Myc, Klf4, Oct4 and Sox2)
is sufficient to reprogram somatic cells to a pluripotent state 1 , 2 , 3 , 4 . The resulting …
is sufficient to reprogram somatic cells to a pluripotent state 1 , 2 , 3 , 4 . The resulting …
The many faces of robustness: A critical analysis of out-of-distribution generalization
…, F Wang, E Dorundo, R Desai… - Proceedings of the …, 2021 - openaccess.thecvf.com
We introduce four new real-world distribution shift datasets consisting of changes in image
style, image blurriness, geographic location, camera operation, and more. With our new …
style, image blurriness, geographic location, camera operation, and more. With our new …
[HTML][HTML] Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
…, GT Demoz, JW De Neve, R Desai… - The Lancet …, 2020 - thelancet.com
Background Previous attempts to characterise the burden of chronic respiratory diseases
have focused only on specific disease conditions, such as chronic obstructive pulmonary …
have focused only on specific disease conditions, such as chronic obstructive pulmonary …
[HTML][HTML] The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of …
Background Cirrhosis and other chronic liver diseases (collectively referred to as cirrhosis
in this paper) are a major cause of morbidity and mortality globally, although the burden and …
in this paper) are a major cause of morbidity and mortality globally, although the burden and …
Maintenance therapy with tumor-treating fields plus temozolomide vs temozolomide alone for glioblastoma: a randomized clinical trial
…, J Sroubek, ND Tran, AF Hottinger, J Landolfi, R Desai… - Jama, 2015 - jamanetwork.com
Importance Glioblastoma is the most devastating primary malignancy of the central nervous
system in adults. Most patients die within 1 to 2 years of diagnosis. Tumor-treating fields (…
system in adults. Most patients die within 1 to 2 years of diagnosis. Tumor-treating fields (…
[HTML][HTML] Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on …
…, M Bua, JF Apperley, R Szydlo, R Desai… - Journal of clinical …, 2010 - ncbi.nlm.nih.gov
Purpose There is a considerable variability in the level of molecular responses achieved with
imatinib therapy in patients with chronic myeloid leukemia (CML). These differences could …
imatinib therapy in patients with chronic myeloid leukemia (CML). These differences could …